Skip to main content
Premium Trial:

Request an Annual Quote

Congenica, UniteGen Ink Deal for Genome Analysis Platform

NEW YORK (GenomeWeb) – Bioinformatics firm Congenica said on Wednesday that it has signed an agreement under which its Sapientia clinical genome analysis software platform will be used by Beijing-based UniteGen as part of a large-scale genomics project in China.

Sapientia is a modular and scalable data analytics tool for annotating and clinically interpreting genomic sequence data. Under the terms of the deal, UniteGen will use the platform to carry out whole-genome sequencing processing and analysis for the 100K Wellness Pioneer Project — a recently launched initiative to analyze the genomes, metabolomes, proteomes, and clinical symptoms of 100,000 Chinese individuals in order to build a database for disease prevention and health management.

Additional terms were not disclosed.

"Sapientia incorporates all the features needed by Chinese healthcare practitioners to integrate genetic testing into clinical decisions," UniteGen Founder and CEO Weike Mo said in a statement. "The automated reporting software solves a critical bottleneck for the genetic testing industry in China."

In mid-2015, Congenica was selected by Genomics England as one of four informatic companies to provide genomic interpretation services for the UK's 100,000 Genomes Project.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.